Germany advised to combine AstraZeneca and mRNA vaccines to brake Delta variant
AstraZeneca
11,352.00p
16:40 24/04/24
Germany's government committee on vaccinations believes combining the Covid-19 vaccine made by AstraZeneca and mRNA ones such as Pfizer's is the best way to combat the so-called Delta variant.
FTSE 100
8,040.38
16:34 24/04/24
FTSE 350
4,419.71
17:09 24/04/24
FTSE All-Share
4,374.06
16:44 24/04/24
MODERNA
$108.85
13:09 24/04/24
Pfizer Inc.
$26.27
11:10 24/04/24
Pharmaceuticals & Biotechnology
21,897.50
17:09 24/04/24
According to the committee (Stiko), the immune response generated from a combination of one shot of each is "clearly superior to that from two doses of AstraZeneca alone".
Its recommendation was for the second jab to be given four week after a first shot with AstraZeneca's vaccine.
At last count, roughly 55% of the total German population had received at least one dose and a further 37.3% the complete vaccine course.
However, according to German health minister, Jens Spahn, starting from June the proportion of infections in Germany from the Delta variant was set to reach 70-80% of the total.